Cargando…

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential

BACKGROUND: Although uniform colonoscopy screening reduces colorectal cancer (CRC) mortality, risk-based screening may be more efficient. We investigated whether CRC screening based on polygenic risk is a cost-effective alternative to current uniform screening, and if not, under what conditions it w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naber, Steffie K, Kundu, Suman, Kuntz, Karen M, Dotson, W David, Williams, Marc S, Zauber, Ann G, Calonge, Ned, Zallen, Doris T, Ganiats, Theodore G, Webber, Elizabeth M, Goddard, Katrina A B, Henrikson, Nora B, van Ballegooijen, Marjolein, Janssens, A Cecile J W, Lansdorp-Vogelaar, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988584/ https://www.ncbi.nlm.nih.gov/pubmed/32025627 http://dx.doi.org/10.1093/jncics/pkz086

Ejemplares similares

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
por: Naber, Steffie K., et al.
Publicado: (2019)

Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?
por: McFerran, Ethna, et al.
Publicado: (2022)

Risk‐stratified strategies in population screening for colorectal cancer
por: Lansdorp‐Vogelaar, Iris, et al.
Publicado: (2021)

Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia
por: Naber, Steffie K., et al.
Publicado: (2021)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk
por: Kundu, Suman, et al.
Publicado: (2016)

Polygenic risk-stratified screening for cancer: Responsibilization in public health genomics
por: Kerr, Anne, et al.
Publicado: (2019)

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study
por: Matthijsse, Suzette M., et al.
Publicado: (2018)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Polygenic risk scores to stratify cancer screening should predict mortality not incidence
por: Vickers, Andrew J., et al.
Publicado: (2022)

Identifying key factors for the effectiveness of pancreatic cancer screening: A model‐based analysis
por: Koopmann, Brechtje D. M., et al.
Publicado: (2021)

The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study
por: Naber, Steffie K., et al.
Publicado: (2016)

Interpretation and adherence to the updated risk-stratified guideline for colonoscopy surveillance after polypectomy – a nationwide survey
por: van der Meulen, Miriam P., et al.
Publicado: (2020)

Proprietary Algorithms for Polygenic Risk: Protecting Scientific Innovation or Hiding the Lack of It?
por: Janssens, A. Cecile J.W.
Publicado: (2019)

Polygenic Risk of Prediabetes, Undiagnosed Diabetes, and Incident Type 2 Diabetes Stratified by Diabetes Risk Factors
por: Liu, Xiaonan, et al.
Publicado: (2023)

Implementation of Risk-Stratified Breast Cancer Prevention With a Polygenic Risk Score Test in Clinical Practice
por: Padrik, Peeter, et al.
Publicado: (2023)

Validity of polygenic risk scores: are we measuring what we think we are?
por: Janssens, A Cecile J W
Publicado: (2019)

Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
por: Pavelka, L., et al.
Publicado: (2022)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)

Cost‐effectiveness of prophylactic hysterectomy in first‐degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study
por: Alblas, Maaike, et al.
Publicado: (2021)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
por: Cenin, Dayna R, et al.
Publicado: (2018)

Risk-Stratified Breast Cancer Screening Incorporating a Polygenic Risk Score: A Survey of UK General Practitioners’ Knowledge and Attitudes
por: Ayoub, Aya, et al.
Publicado: (2023)

Publisher Correction: Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
por: Pavelka, L., et al.
Publicado: (2022)

Harnessing Whole Genome Polygenic Risk Scores to Stratify Individuals Based on Cardiometabolic Risk Factors and Biomarkers at Age 10 in the Lifecourse—Brief Report
por: Richardson, Tom G., et al.
Publicado: (2022)

Genetic risk for schizophrenia is associated with altered visually-induced gamma band activity: evidence from a population sample stratified polygenic risk
por: Dimitriadis, S. I., et al.
Publicado: (2021)

Evaluation of Polygenic Risk Models Using Multiple Performance Measures: A Critical Assessment of Discordant Results
por: Martens, Forike K., et al.
Publicado: (2018)

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History
por: van den Broek, Jeroen J, et al.
Publicado: (2020)

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores
por: Page, Madeline L., et al.
Publicado: (2022)

Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
por: Meester, Reinier G S, et al.
Publicado: (2015)

652: IMPACT AND RECOVERY FROM COVID-19-RELATED DISRUPTIONS IN COLORECTAL CANCER SCREENING AND CARE: A SCENARIO ANALYSIS
por: Puttelaar, Rosita van den, et al.
Publicado: (2022)

Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis
por: van den Puttelaar, Rosita, et al.
Publicado: (2023)

Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk
por: Palk, A. C., et al.
Publicado: (2019)

Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries
por: Liang, Yanyu, et al.
Publicado: (2022)

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

A personalized and dynamic risk estimation model: The new paradigm in Barrett’s esophagus surveillance
por: Roumans, Carlijn A. M., et al.
Publicado: (2022)

Association Between Polygenic Risk Score and Risk of Myopia
por: Ghorbani Mojarrad, Neema, et al.
Publicado: (2019)

Polygenic risk scores in the clinic: Translating risk into action
por: Lewis, Anna C.F., et al.
Publicado: (2021)

Polygenic Risk Score and Risk Factors for Gestational Diabetes
por: Perišić, Marija Majda, et al.
Publicado: (2022)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fo3mnt4h0p17cju5fbnipsf00c